Engineering Biology (EngBio) is an emerging field at the confluence of Biology, Chemistry, Engineering, AI and Data Science. It has the potential to provide innovative solutions to these challenges by ...

Conservation biology is the study of attempts to protect and preserve biodiversity. It focuses on both the biological and social factors that affect the success of conservation efforts and on ...

Re­gen­eron, mak­er of the block­buster oph­thal­mol­o­gy med­i­cine Eylea, has ac­quired an oc­u­lar biotech, the large bio­phar­ma con­firmed to End­points News on Thurs­day.

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...

2024 was the year of the pri­vate megaround. Nine-fig­ure fi­nanc­ings dom­i­nat­ed biotech’s ven­ture fund­ing land­scape, with 96 such rounds tal­lied by End­points News. The bevy … ...

Built by Biology just as Nature intended.” As of Sept. 30, 2024, the company had cash and cash equivalents of $25,297. Last week, the company entered into a securities purchase agreement with ...

Figure 1 Schematic diagram of CRISPR/Cas9 plant transformation vector pKSE401. Oligonucleotides of gRNA sequence were annealed and then inserted at the BsaI-digestion site between the pU6-26 promoter ...

The biotechnology sector once again starts a new year on shaky footing. Acquisitions of publicly traded biotech companies have slowed. An anticipated upswing in initial public offerings hasn’t ...

Researchers have opened a transformative chapter in agricultural biotechnology by unveiling ... The first utilizes the tobacco rattle virus (TRV) vector to deliver single guide RNAs (sgRNAs ...

However, China’s influence in global R&D has grown significantly, with expanding clinical trial activity and first-to-market launches. All the news that moves the needle in pharma and biotech ...